SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001615774-19-002242
Filing Date
2019-02-11
Accepted
2019-02-11 16:10:51
Documents
4
Period of Report
2019-04-05
Effectiveness Date
2019-02-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A s115994_def14a.htm DEF 14A 507122
2 GRAPHIC s115994_img1.jpg GRAPHIC 322769
3 GRAPHIC s115994_proxy1.jpg GRAPHIC 272892
4 GRAPHIC s115994_proxy2.jpg GRAPHIC 305622
  Complete submission text file 0001615774-19-002242.txt   1749950
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-37606 | Film No.: 19585497
SIC: 8731 Services-Commercial Physical & Biological Research